New members joining the PFMD partnership

by | 9 Apr 2018

Patient engagement in practice
Patient engagement in practice

Our community continues to grow.
This year already we have welcomed Sheffield Biomedical Research Centre and Sant Joan de Déu Research Foundation (FSJD) into the PFMD family. Our rapid expansion is evidence of the growing momentum behind taking the right approach to patient engagement.

Tags:

What expertise is required to make an impact in patient engagement?

by | May 12, 2022

New European health partnership promises to boost patient involvement 

by | March 25, 2022

Remuneration for patients interacting with the Pharma industry: strong support to develop Global Principles

by | February 16, 2022

Are cardiovascular patients ready for the digital revolution? 

by | December 13, 2021

How tailored training and guidance could help medtech involve patients

by | October 27, 2021

Patient remuneration: have your say

by | October 25, 2021

Wanted: a global approach to patient remuneration

by | October 6, 2021

Fast-moving medtech accelerating pivot towards patient engagement

by | September 14, 2021

Medtech & patient engagement: could ‘quick wins’ help industry respond to a growing trend? 

by | September 14, 2021

Digital health: how patients can shape responsible data management 

by | August 23, 2021

Hearing the voices of children in medicines R&D

by | August 23, 2021

The use of patient experience data is reaching a ‘tipping point’, say experts

by | July 19, 2021

PEOF 2021: Patient Engagement to design, generate, analyze and decide on Patient Experience Data

by | June 18, 2021

Co-creation in patient engagement – “it’s time to roll up our sleeves”

by | June 18, 2021

From PE Metrics Framework to Actionable Tool – What’s After PARADIGM? 

by | June 18, 2021

PEOF 2021 How to Connect Patients to Digital Health

by | June 11, 2021

Putting cardiovascular patients at the heart of the technology revolution

by | June 3, 2021

The road to patient-centred medtech

by | May 28, 2021

Parkinson’s disease: what medtech companies can learn from patients

by | May 17, 2021

Virtual events: tips for patient organisations

by | March 4, 2021

The challenges of engaging patients with rare diseases 

by | February 26, 2021

Coping with COVID: Pandemic putting pressure on vulnerable patients 

by | February 3, 2021

“A pioneering opportunity”: piloting the first How-To Guide

by | January 26, 2021

Meaningful patient engagement proved “invaluable” during pandemic

by | January 19, 2021

How patients can make a real impact with virtual events

by | January 13, 2021

‘COVID-19 survivors are coming out as kidney patients’ 

by | January 6, 2021

Bringing the trial to the patient

by | December 16, 2020

Supporting arthritis patients through the pandemic 

by | December 15, 2020

Stress, anxiety and loneliness: how the pandemic added to the burden of people with dementia  

by | December 8, 2020

Pandemic hits patient engagement 

by | December 3, 2020

Is MedTech ready for patient engagement? 

by | November 23, 2020

COVID-19’s twin threat for cancer patients

by | November 20, 2020

‘Want to discuss patient engagement? Do this training first’

by | November 18, 2020

Patient engagement training: changing company culture one step at a time

by | November 12, 2020

Should a ‘PE license’ be mandatory to work in the medicines ecosystem?

by | October 9, 2020

Novartis leadership support boosts Patient Engagement training for employees

by | October 2, 2020

How COVID-19 changes clinical trials – for good

by | August 31, 2020

The final piece of the puzzle: capacity building in patient engagement

by | June 24, 2020

A shared vision: bringing empowered patients to the table

by | June 22, 2020

Patient information leaflets: “Putting patients’ needs first is vitally important”

by | June 9, 2020

5 minutes with…Doug Noland, Executive Director, Patient Partnerships, Astellas Pharma

by | June 3, 2020

Researchers and patients benefit from co-designing clinical trials – a new guide aims to make it easier to collaborate

by | May 27, 2020

Implementing patient engagement in clinical trial design: challenges and opportunities

by | May 19, 2020

Protecting everyone’s interests: the RAPP project

by | May 13, 2020

Involving patients in drug development – from the start

by | May 12, 2020

Training can help to build capacity for patient engagement

by | May 5, 2020

Ensuring the patient’s voice is heard

by | April 23, 2020

“We need to take patient involvement to new levels”

by | April 21, 2020

‘We need to build infrastructure to support patient-centricity’ 

by | April 15, 2020

‘HTA bodies and regulators have a shared interest in understanding patient experiences’

by | April 8, 2020

Nobody has ever regretted patient engagement

by | March 30, 2020

Plain language summaries now a publishing requirement in drug safety journal

by | February 20, 2020

5 minutes with… Jessica Scott, Head of R&D Patient Engagement Office, Takeda  

by | February 12, 2020

Acknowledging the value of patient input

by | February 5, 2020

5 minutes with… the American Migraine Foundation

by | January 9, 2020

Unlocking the potential of cohort studies

by | October 4, 2019

A PE trailblazer committed to improving patients’ lives

by | September 23, 2019

Developing the patient engagement system

by | September 19, 2019

Doctors are paid for their expertise, what about patients?

by | September 5, 2019

Calculating reimbursement rates for patient engagement in medicines development

by | September 3, 2019

Applying the Patient Engagement Quality Guidance across a whole organisation – the INVOLVE experience

by | August 16, 2019

How the National Kidney Foundation is piloting the PEQG

by | July 25, 2019

Putting patient engagement on the map at ISPOR US

by | July 18, 2019

Making the case for patient engagement

by | July 8, 2019

Patients & partnership: involving citizens in shaping the future of healthcare 

by | July 1, 2019

EU must prioritise patient engagement in health research 

by | June 26, 2019

Piloting the Patient Engagement Quality Guidance in health technology assessment

by | June 18, 2019

How Parkinson’s UK is piloting the Patient Engagement Quality Guidance

by | June 11, 2019

EU researchers to have access to ‘pool’ of patient experts

by | June 3, 2019

FDA calls on industry to speed up trials process

by | April 29, 2019

New medicines 19% more likely to launch when trials are co-designed with patients

by | April 24, 2019

Wisdom of the crowd: how the public can help decide what research to fund

by | April 4, 2019

Different patients, different solutions: PFMD at the EFGCP Annual Meeting

by | March 18, 2019

The wide-ranging impact of patient access

by | February 27, 2019

Patient health data: translating stories into science

by | April 25, 2022

Determining Fair Market Value: Demystifying the methodology behind patient remuneration

by | March 25, 2022

Get the latest information on Patient Focused Medicines Development and stay connected with our activities.